UASt regulatory sequences drive expression of an inverted repeat.
bouton, with Scer\GAL4C57
synapse, with Scer\GAL4C57
Hemocyte trans-migration from the head to the tail is similar in embryos expressing Arp3GD12273 under the control of Scer\GAL4Pxn.PS and wild-type. However, compared with wild-type, expression of Scer\GAL4Pxn.PS>Arp3GD12273 significantly reduces the number of hemocytes that migrate anteriorly from the tail along the ventral midline. Scer\GAL4Pxn.PS>Arp3GD12273 hemocytes are also less organized resulting in the simultaneous formation of three lines of hemocytes migrating posteriorly from the head rather than the lateral movement of hemocytes from the ventral midline observed in wild-type embryos.
Compared with wild-type, posterior hemocytes in Scer\GAL4Pxn.PS>Arp3GD12273 embryos exhibit severe reduction in cellular protrusion area. The anterior hemocytes of the same genotype also show a moderate reduction in cellular protrusion area. The number of vacuoles present in both the anterior and posterior hemocyte cell bodies is increased relative to wild-type.
Larvae expressing Arp3GD12273 under the control of Scer\GAL4Ubi have neuromuscular junction (NMJ) defects. The number of type Ib boutons per NMJ and the number of axonal branch points per NMJ are significantly reduced compared to controls.
Larvae expressing Arp3GD12273 under the control of Scer\GAL4VGlut-OK371 show a significant reduction in the number of type Ib boutons per NMJ compared to controls, but the number of axonal branch points per NMJ is not significantly affected.
The average speed of migration of third instar larvae expressing Arp3GD12273 under the control of Scer\GAL4Ubi is significantly reduced compared to wild type.
Muscle-specific expression of Arp66BGD12273 under the control of Scer\GAL4C57 results in synaptic overgrowth.
Adults expressing Arp3GD12273 under the control of the cardioblast-specific Scer\GAL4tin.CΔ4 driver show significantly reduced survival on day 6 after a shift to 29[o]C compared to control flies.
Adults expressing Arp3GD12273 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in viable flies or late pupal lethality.
Expression under the control of Scer\GAL4pnr-MD237 may result in semi-lethality, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in loss of bristles on the notum in 0% or 30-40% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in bristle morphology defects on the notum in 0% or 30-40% of the Scer\GAL4pnr-MD237 expression domain, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 0% or 40-50% of the Scer\GAL4pnr-MD237-expressing area of the notum, depending on the insertion line used.
Arp3GD12273, Scer\GAL4ptc.PU is a suppressor of visible | adult stage phenotype of DoraGD6527, Scer\GAL4ptc.PU
Arp3GD12273, Arpc1GD14085, Scer\GAL4A3.eya has male sterile phenotype
Arp3GD12273, Scer\GAL4ptc.PU is a suppressor of wing hair phenotype of DoraGD6527, Scer\GAL4ptc.PU
Arp3GD12273, Arpc1GD14085, Scer\GAL4A3.eya has seminal vesicle phenotype
Arp3GD12273, Arpc1GD14085, Scer\GAL4A3.eya has spermatid cyst phenotype
Larvae co-expressing Arp66BGD12273 and Sop2GD14085 under the control of Scer\GAL4moody.PK show an increased penetration of 3kD fluorescein-dextran into the ventral nerve cord in a permeability assay compared to the dye penetration seen in control larvae.
Co-expression of Arpc1GD14085, Arp3GD12273 and Dcr-2Scer\UAS.cDa under the control of Scer\GAL4A3.eya results in a male-sterile phenotype, characterised by spermatogenic arrest at the elongated cyst stage and empty seminal vesicles.
Co-expression of Sop2GD14085 and Arp66BGD12273 under the control of Scer\GAL4btl.PS in embryos does not alter apical F-actin in the trachea.
Co-expression of Sop2GD14085 and Arp66BGD12273 under the control of Scer\GAL4Mef2.PR in embryos results in a muscle fusion phenotype.